Erdinandus Hartono, - and Prihartini Widiyanti, - and Andi Hamim Zaidan, - (2023) In Vivo Studies of Magnetic Nanoparticles-Folic Acid (FA) Functionalized for Breast Cancer Targeting Drug Carrier. 8th International Conference and Workshop on Basic and Applied Science, ICOWOBAS 2021. ISSN 0094-243X

	Text (Artikel) Artikel AIP In vivo MNP.pdf Download (1MB)
	Text (Turnitin) Turnitin In Vivo Studies of Magnetic Nanoparticle.pdf Download (3MB)

Abstract

Abstract. The number of cancer patients in the world is constantly increasing and it is considered as one of the deadliest among other diseases. There are urgent needs of effective and efficient medicine for late-stage cancer since none of current treatment has promising outcome especially related chemotherapy's side effects. Magnetic nanoparticles with its ability to be modified, coated and functionalized is a candidate for drug delivery's targeting carrier. This research goal was proposing a novel drug carrier to specifically target cancer cells without any significant remnant in other tissues. Our method begun with MNP coating using bovine serum albumin then functionalized with folic acid as targeting agent. Multiple evaluations towards functionalized MNP includes: MTT Assay for its toxicity, in vivo test for targeting capability assessment, and histopathology test for host's cellular response. The results showed that the magnetic nanoparticles-FA functionalized was non-toxic, no significant cellular damage, and it had a promising result to be used for further cancer targeting study.

Actions (login required)

View Item